Inter-site pair superconductivity: origins and recent validation experiments

The challenge of understanding high-temperature superconductivity has led to a plethora of ideas, but 30 years after its discovery in cuprates, very few have achieved convincing experimental validation. While Hubbard and t-J models were given a lot of attention, a number of recent experiments appear to give decisive support to the model of real-space inter-site pairing and percolative superconductivity in cuprates. Systematic measurements of the doping dependence of the superfluid density show a linear dependence on superfluid density - rather than doping - over the entire phase diagram, in accordance with the model's predictions. The doping-dependence of the anomalous lattice dynamics of in-plane Cu-O mode vibrations observed by inelastic neutron scattering, gives remarkable reciprocal space signature of the inter-site pairing interaction whose doping dependence closely follows the predicted pair density. Symmetry-specific time-domain spectroscopy shows carrier localization, polaron formation, pairing and superconductivity to be distinct processes occurring on distinct timescales throughout the entire superconducting phase diagram. The three diverse experimental results confirm non-trivial predictions made more than a decade ago by the inter-site pairing model in the cuprates, remarkably also confirming some of the fundamental notions mentioned in the seminal paper on the discovery of high-temperature superconductivity in cuprates.Comment: Dedicated to Prof. K. A. Mueller on the Occasion of his 90th Birthda

Antioxidant effect of Morus nigra on Chagas disease progression

ABSTRACT Considering the widespread popular use of Morus nigra and the amount of scientific information on its antioxidant and anti-inflammatory activity, the effectiveness of this phytotherapeutic compound in the parasitemia progression during the acute phase of Chagas disease and its role in the development of the inflammatory process as well as its effects on the oxidative damage in the chronic phase of infection were evaluated. Thus, 96 male Swiss mice were randomly divided into eight groups, four groups were uninfected controls, and four groups were intraperitoneally infected with 5.0 x 104 blood trypomastigotes forms of T. cruzi QM2 strain. Four batches composed of one uninfected and one infected group were respectively treated with 70% alcohol solution and 25 μL, 50 μL and 75 μL of the phytotherapeutic compound. Levels of antioxidant elements (TBARS, FRAP, GSH and Sulfhydryl groups) were measured in plasma samples. The phytotherapeutic compound’s antioxidant activity was measured by polyphenol and total flavonoid quantification, DPPH, NO, and FRAP method. Our results showed that the vehicle influenced some of the results that may have physiological relevance in Chagas disease. However, an important action of M. nigra tincture was observed in the progression of Chagas disease, since our results demonstrated a reduction in parasitemia of treated groups when compared to controls, especially in the group receiving 25 µL. However, in the chronic phase, the 50-µL dosage presented a better activity on some antioxidant defenses and minimized the tissue inflammatory process. Results indicated an important action of M. nigra tincture on the Chagas disease progression